CLRB (Cellectar Biosciences) OCF Yield %: -92.26 (As of Jun. 26, 2026)


CLRB Cellectar Biosciences Inc CLRB
28 GF Score
Price $2.50
! 1 Warning Sign
View Full Analysis

What is Cellectar Biosciences OCF Yield %?

Cellectar Biosciences CLRB +1.20% 28 OCF Yield % is -92.26 as of Jun. 26, 2026. GuruFocus rates CLRB with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 1,419 Biotechnology companies, Cellectar Biosciences ranks worse than 89.99% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Cellectar Biosciences's Trailing 12-Month Cash Flow from Operations is $-18.58 Mil, and Market Cap is $19.99 Mil. Therefore, Cellectar Biosciences's OCF Yield % for today is -92.26%.

The historical rank and industry rank for Cellectar Biosciences's OCF Yield % or its related term are showing as below:

CLRB' s OCF Yield % Range Over the Past 10 Years
Min: -94.13   Med: 0   Max: -91.53
Current: -92.26


During the past 13 years, the highest OCF Yield % of Cellectar Biosciences was -91.53%. The lowest was -94.13%. And the median was %.

CLRB's OCF Yield % is ranked worse than
89.99% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs CLRB: -92.26

Cellectar Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Cellectar Biosciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Cellectar Biosciences OCF Yield % Related Terms


Cellectar Biosciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Cellectar Biosciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellectar Biosciences OCF Yield % Chart

Cellectar Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -55.54 -157.08 -56.38 -345.36 -184.83

Cellectar Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -258.32 -158.84 -95.66 -138.92 -179.99

CLRB vs PTN, PLUR, VTGN: OCF Yield % Comparison

For the Biotechnology subindustry, Cellectar Biosciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellectar Biosciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectar Biosciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Cellectar Biosciences's OCF Yield % falls into.


CLRB
28GF Score
Cellectar Biosciences Inc CLRB
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellectar Biosciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Cellectar Biosciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-23.118 / 12.508
=-184.83%

Cellectar Biosciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-4.846 * 4 / 10.7696
=-179.99%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -92.26 mean?
Cellectar Biosciences (CLRB) has a OCF Yield % of -92.26 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cellectar Biosciences and its competitors. According to the industry distribution chart, Cellectar Biosciences ranks #1277 out of 1419 companies in the Biotechnology industry, placing it in the top 90%.
Is Cellectar Biosciences' OCF Yield % too high?
Cellectar Biosciences' current OCF Yield % is -92.26. Based on the distribution chart, Cellectar Biosciences ranks #1277 out of 1419 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Cellectar Biosciences has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Cellectar Biosciences' OCF Yield % compare to PTN and PLUR?
According to the Biotechnology industry distribution chart, Cellectar Biosciences ranks #1277 out of 1419 companies for OCF Yield %. This places Cellectar Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cellectar Biosciences and its competitors. Cellectar Biosciences's current OCF Yield % is -92.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellectar Biosciences stock overvalued right now?
Cellectar Biosciences (CLRB) has a current OCF Yield % of -92.26. The current OCF Yield % is -92.26. Cellectar Biosciences' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Cellectar Biosciences (CLRB), the current OCF Yield % is -92.26 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellectar Biosciences Business Description

Address 100 Campus Drive, Florham Park, NJ, USA, 07932
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
28GF Score

Get the complete analysis for CLRB

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.50
Price